Heerspink HJL, Stefansson BV, Chertow GM, Correa-Rotter R, et al. Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial. Nephrol Dial Transplant 2020;35:274-282.
PMID: 32030417